• Supriya Malappa Talavar
• Ganesh R. Phadtare
• Sanjay R. Arote

This research project investigates the inhibitory activities of the monoamine oxidase (MAO) enzyme in Epipremnum aureum, a common houseplant known for its potential medicinal properties. MAO is an enzyme responsible for the breakdown of monoamine neurotransmitters, and its inhibition is a target for the treatment of various neurological disorders, including depression and Parkinson's disease. This study aims to identify and quantify the inhibitory effects of Epipremnum aureum extracts on MAO activity. Using in vitro assays, we analyzed the enzymatic activity in the presence of plant extracts, comparing the results to standard inhibitors. The findings indicate significant inhibitory effects, suggesting that Epipremnum aureum may contain bioactive compounds with potential therapeutic applications. Further phytochemical analysis and bioactivity-guided fractionation are recommended to isolate and identify the active constituents responsible for MAO inhibition. This study contributes to the understanding of the medicinal potential of Epipremnum aureum and supports its use in developing novel treatments for neurological disorders.

Neurotransmitters, Monoamine oxidase (MAO), Enzyme inhibition, Epipremnum aureum, Phytochemicals, MAO inhibitors, Plant extracts, Antidepressant activity, Antioxidant properties, Enzymatic assay.

"Inhibitory effects of Monoamine Oxidase enzyme in Epipremnum aureum: An Assessment", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 7, page no.a907-a920, July-2024, Available :http://www.jetir.org/papers/JETIR2407092.pdf

"Inhibitory effects of Monoamine Oxidase enzyme in Epipremnum aureum: An Assessment", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 7, page no. ppa907-a920, July-2024, Available at : http://www.jetir.org/papers/JETIR2407092.pdf